A20 Inhibitors For The Treatment Of Respiratory Viral Infections


The present invention relates to the field of medicine, more particularly to the field of viral pneumonia. The invention shows that inhibition of A20 in respiratory epithelium and also the inhibition of A20 in alveolar macrophages results in an accelerated clearance of virus infected lungs. Accordingly, the invention provides for inhibitors of A20 and their use for the treatment of viral infections, more particularly viral lung infections such as influenza.

Download PDF
Document Preview
Document History
  • Publication: Dec 27, 2012
  • Application: Jun 25, 2012
    WO EP 2012062227 W
  • Priority: Jun 23, 2011
    US US 201161571316 P

Download Citation

Sign in to the Lens